Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Role of myeloid-derived suppressor cells in mouse pre-sensitized cardiac transplant model.

Gong W, Ge F, Liu D, Wu Y, Liu F, Kim BS, Huang T, Koulmanda M, Robson SC, Strom TB.

Clin Immunol. 2014 Jul;153(1):8-16. doi: 10.1016/j.clim.2014.03.013. Epub 2014 Mar 30.

PMID:
24691417
2.

Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide.

Liao J, Wang X, Bi Y, Shen B, Shao K, Yang H, Lu Y, Zhang Z, Chen X, Liu H, Wang J, Chu Y, Xue L, Wang X, Liu G.

J Leukoc Biol. 2014 Nov;96(5):675-84. doi: 10.1189/jlb.2HI1113-611RR. Epub 2014 Jun 19.

PMID:
24948701
3.

miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.

Liu Q, Zhang M, Jiang X, Zhang Z, Dai L, Min S, Wu X, He Q, Liu J, Zhang Y, Zhang Z, Yang R.

Int J Cancer. 2011 Dec 1;129(11):2662-73. doi: 10.1002/ijc.25921. Epub 2011 Mar 25.

4.

Alteration of innate immunity by donor IL-6 deficiency in a presensitized heart transplant model.

Ge F, Yuan S, Su L, Shen Z, He A, Huang T, Gong W.

PLoS One. 2013 Oct 16;8(10):e77559. doi: 10.1371/journal.pone.0077559. eCollection 2013.

5.

Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.

Zhang W, Liang S, Wu J, Horuzsko A.

Transplantation. 2008 Oct 27;86(8):1125-34. doi: 10.1097/TP.0b013e318186fccd.

6.

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model.

Gong W, Liu B, Chen J, Liu C, Shen Z.

Ann Transplant. 2018 Apr 13;23:246-251.

7.

Presensitized immune condition of host exaggerates prolonged cold ischemia-mediated injury of cardiac graft involving regulatory T cells.

Gong W, Huang T, Ge F, Luo G, Yuan S, Gao D, Kong D.

Transplantation. 2013 Oct 15;96(7):609-15. doi: 10.1097/TP.0b013e31829df26d.

PMID:
23880577
8.

Tolerance induced by IL-6 deficient donor heart is significantly involved in myeloid-derived suppressor cells (MDSCs).

Gong W, Shou D, Cheng F, Shi J, Ge F, Liu D.

Transpl Immunol. 2015 Mar;32(2):72-5. doi: 10.1016/j.trim.2015.02.001. Epub 2015 Feb 10.

PMID:
25680847
9.

IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.

Turnquist HR, Zhao Z, Rosborough BR, Liu Q, Castellaneta A, Isse K, Wang Z, Lang M, Stolz DB, Zheng XX, Demetris AJ, Liew FY, Wood KJ, Thomson AW.

J Immunol. 2011 Nov 1;187(9):4598-610. doi: 10.4049/jimmunol.1100519. Epub 2011 Sep 26.

10.

Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway.

Wu T, Sun C, Chen Z, Zhen Y, Peng J, Qi Z, Yang X, Zhao Y.

J Immunol. 2012 Nov 15;189(10):4989-5000. doi: 10.4049/jimmunol.1200068. Epub 2012 Oct 8.

11.

Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.

Greifenberg V, Ribechini E, Rössner S, Lutz MB.

Eur J Immunol. 2009 Oct;39(10):2865-76. doi: 10.1002/eji.200939486.

12.

A role for immature myeloid cells in immune senescence.

Enioutina EY, Bareyan D, Daynes RA.

J Immunol. 2011 Jan 15;186(2):697-707. doi: 10.4049/jimmunol.1002987. Epub 2010 Dec 10.

13.

Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow.

Poh TW, Bradley JM, Mukherjee P, Gendler SJ.

Cancer Res. 2009 Apr 15;69(8):3554-62. doi: 10.1158/0008-5472.CAN-08-3806. Epub 2009 Apr 7.

14.

The calcineurin-NFAT axis controls allograft immunity in myeloid-derived suppressor cells through reprogramming T cell differentiation.

Wang X, Bi Y, Xue L, Liao J, Chen X, Lu Y, Zhang Z, Wang J, Liu H, Yang H, Liu G.

Mol Cell Biol. 2015 Feb;35(3):598-609. doi: 10.1128/MCB.01251-14. Epub 2014 Dec 1.

15.

Preemptive donor apoptotic cell infusions induce IFN-γ-producing myeloid-derived suppressor cells for cardiac allograft protection.

Bryant J, Lerret NM, Wang JJ, Kang HK, Tasch J, Zhang Z, Luo X.

J Immunol. 2014 Jun 15;192(12):6092-101. doi: 10.4049/jimmunol.1302771. Epub 2014 May 7.

16.

Functional characterization of myeloid-derived suppressor cell subpopulations during the development of experimental arthritis.

Wang W, Jiao Z, Duan T, Liu M, Zhu B, Zhang Y, Xu Q, Wang R, Xiong Y, Xu H, Lu L.

Eur J Immunol. 2015 Feb;45(2):464-73. doi: 10.1002/eji.201444799. Epub 2014 Nov 28.

17.

Gr1(int)CD11b+ myeloid-derived suppressor cells in Mycobacterium tuberculosis infection.

Obregón-Henao A, Henao-Tamayo M, Orme IM, Ordway DJ.

PLoS One. 2013 Nov 1;8(11):e80669. doi: 10.1371/journal.pone.0080669. eCollection 2013.

18.

The roles of myeloid-derived suppressor cells in transplantation.

Wu T, Zhao Y, Zhao Y.

Expert Rev Clin Immunol. 2014 Oct;10(10):1385-94. doi: 10.1586/1744666X.2014.948424. Epub 2014 Aug 13. Review.

PMID:
25119260
19.

Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.

Hamilton MJ, Bosiljcic M, Lepard NE, Halvorsen EC, Ho VW, Banáth JP, Krystal G, Bennewith KL.

J Immunol. 2014 Jan 1;192(1):512-22. doi: 10.4049/jimmunol.1300096. Epub 2013 Nov 27.

20.

Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin.

Munera V, Popovic PJ, Bryk J, Pribis J, Caba D, Matta BM, Zenati M, Ochoa JB.

Ann Surg. 2010 Jan;251(1):120-6. doi: 10.1097/SLA.0b013e3181bfda1c.

PMID:
20032720

Supplemental Content

Support Center